ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 939

$1.19M Total Retail Price of All Prescriptions

Rank: 25 out of 939

1,250 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 1,250 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 24,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
OMEPRAZOLE 1,072 875 1 5
LEVOTHYROXINE SODIUM 1,056 879 2 4
SIMVASTATIN 1,035 859 3 2
LISINOPRIL 1,005 878 4 3
ATENOLOL 947 809 5 19
AMLODIPINE BESYLATE 792 712 6 6
GABAPENTIN 703 615 7 11
POTASSIUM CHLORIDE 672 523 8 9
LOVASTATIN 665 554 9 46
GLIMEPIRIDE 612 512 10 37
METOPROLOL SUCCINATE 589 530 11 21
METFORMIN HCL 558 461 12 8
FUROSEMIDE 549 434 13 7
PRAVASTATIN SODIUM 483 399 14 13
ISOSORBIDE MONONITRATE ER 470 449 15 53
FENOFIBRATE 444 375 16 83
TAMSULOSIN HCL 399 372 17 27
HYDROCHLOROTHIAZIDE 395 301 18 12
CARVEDILOL 334 300 19 25
MELOXICAM 334 269 19 14
METOPROLOL TARTRATE 327 272 21 10
NEXIUM 324 236 22 18
CEPHALEXIN 323 248 23 77
CITALOPRAM HBR 314 193 24 15
ZOLPIDEM TARTRATE 310 282 25 20
ATORVASTATIN CALCIUM 296 269 26 22
TRIAMTERENE-HCTZ 295 239 27 33
CLOPIDOGREL 294 262 28 28
TRAMADOL HCL 288 214 29 16
WARFARIN SODIUM 283 226 30 17
FLUOXETINE HCL 281 200 31 47
AZITHROMYCIN 267 212 32 32
ALLOPURINOL 259 204 33 31
SERTRALINE HCL 233 191 34 24
SPIRONOLACTONE 231 208 35 71
TORSEMIDE 231 217 35 184
CRESTOR 228 201 37 34
HYDROCODONE-ACETAMINOPHEN 216 170 S3 38 1
PLAVIX 204 179 39 48
TRIAMTERENE-HYDROCHLOROTHIAZID 195 175 40 115
CIPROFLOXACIN HCL 190 153 41 54
LOSARTAN POTASSIUM 189 142 42 29
AMITRIPTYLINE HCL 181 136 R 43 38
FAMOTIDINE 180 127 44 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 163 45 23
ROPINIROLE HCL 175 145 46 78
DIOVAN 174 160 47 50
DICLOFENAC SODIUM 169 122 48 93
FOSINOPRIL SODIUM 159 96 49 199
PROAIR HFA 158 100 50 41
ALENDRONATE SODIUM 151 136 51 40
POLYETHYLENE GLYCOL 3350 150 136 52 57
FINASTERIDE 145 145 53 131
SINGULAIR 142 111 54 101
DONEPEZIL HCL 141 138 55 30
BENAZEPRIL HCL 136 106 56 87
CEFDINIR 133 106 57 142
AMIODARONE HCL 122 113 58 160
GLYBURIDE 120 93 R 59 89
PANTOPRAZOLE SODIUM 119 85 60 66
ACETAMINOPHEN-CODEINE 117 97 S3 61 116
CLONIDINE HCL 111 96 62 39
AMOXICILLIN 111 69 62 92
TERAZOSIN HCL 110 107 64 114
ADVAIR DISKUS 106 70 65 60
PAROXETINE HCL 104 72 66 70
CLOTRIMAZOLE-BETAMETHASONE 102 77 67 188
DIOVAN HCT 100 91 68 74
LOSARTAN-HYDROCHLOROTHIAZIDE 100 75 68 55
GLYBURIDE MICRONIZED 98 98 R 70 210
GLIPIZIDE 94 90 71 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 78 72 64
MONTELUKAST SODIUM 93 70 72 172
DIGOXIN 90 90 74 45
TIZANIDINE HCL 89 68 75 81
SYNTHROID 88 82 76 75
ESTRADIOL 88 61 R 76 79
CYMBALTA 85 19 78 44
GLYBURIDE-METFORMIN HCL 84 61 R 79 98
ESCITALOPRAM OXALATE 83 64 80 61
BENICAR 83 69 80 222
ENALAPRIL MALEATE 82 57 82 65
HYDRALAZINE HCL 82 75 82 130
SYMBICORT 81 43 84 137
LEVOFLOXACIN 79 63 85 86
PREDNISONE 78 44 86 42
VENTOLIN HFA 77 27 87 80
LANTUS 74 45 88 59
INSULIN SYRINGE 73 47 89 97
CELEBREX 71 57 90 106
DICYCLOMINE HCL 71 53 90 194
ZETIA 70 65 92 103
FLUCONAZOLE 70 50 92 140
ONGLYZA 70 46 92 241
AMLODIPINE BESYLATE-BENAZEPRIL 68 65 95 58
CYCLOBENZAPRINE HCL 67 41 R 96 36
HYDROCORTISONE 67 61 96 369
RAMIPRIL 67 52 96 91
DOXAZOSIN MESYLATE 65 61 99 108
DETROL LA 64 60 100 155
TRICOR 62 61 101 143
TRAZODONE HCL 62 30 101 26
PHENYTOIN SODIUM EXTENDED 61 61 103 99
OXYBUTYNIN CHLORIDE 61 49 103 125
QUINAPRIL HCL 60 57 105 133
DOXYCYCLINE HYCLATE 60 40 105 84
RANITIDINE HCL 59 30 107 35
LIPITOR 59 58 107 127
COMBIVENT 58 27 109 120
NAMENDA 57 52 110 49
IBUPROFEN 56 35 111 112
PROPRANOLOL HCL 55 54 112 117
MECLIZINE HCL 53 39 113 134
RANEXA 53 53 113 248
CARBIDOPA-LEVODOPA 51 35 115 102
COUMADIN 50 50 116 294
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 32 116 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.